Research on human bladder cancer may shed light into this seemingly paradoxical situation: Wu et al.18proposed that overexpression of LOXL1 and LOXL4 exhibits tumor suppressive action through inhibition of the Ras/ERK signaling pathway in bladder cancer cells. This evidence concerns the gene LOXL1 and urinary bladder carcinoma.